SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiyun Deng, Guangchun He, Junwen Liu, Feijun Luo, Xiaoning Peng, Shigang Tang, Zhiyong Gao, Qinlu Lin, Jill M. Keller, Tao Yang, Evan T. Keller, Recent Advances in Bone-Targeted Therapies of Metastatic Prostate Cancer, Cancer Treatment Reviews, 2014,

    CrossRef

  2. 2
    T Kallunki, O D Olsen, M Jäättelä, Cancer-associated lysosomal changes: friends or foes?, Oncogene, 2013, 32, 16, 1995

    CrossRef

  3. 3
    M. Ishida, F. Kojima, H. Okabe, Cathepsin K expression in basal cell carcinoma, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 1
  4. 4
    Seok-Ho Kim, Eunyoung Lee, Kyung Hye Baek, Han Byeol Kwon, Hyunjung Woo, Eung-Seok Lee, Youngjoo Kwon, Younghwa Na, Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents, Bioorganic & Medicinal Chemistry Letters, 2013, 23, 11, 3320

    CrossRef

  5. 5
    Ilaria Roato, Interaction among Cells of Bone, Immune System, and Solid Tumors Leads to Bone Metastases, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  6. 6
    M K Herroon, E Rajagurubandara, D L Rudy, A Chalasani, A L Hardaway, I Podgorski, Macrophage cathepsin K promotes prostate tumor progression in bone, Oncogene, 2013, 32, 12, 1580

    CrossRef

  7. 7
    Arjun Muralidharan, Maree T. Smith, Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments, Inflammopharmacology, 2013, 21, 5, 339

    CrossRef

  8. 8
    Kyung Hye Baek, Radha Karki, Eung-Seok Lee, Younghwa Na, Youngjoo Kwon, Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors, Bioorganic Chemistry, 2013, 51, 24

    CrossRef

  9. 9
    Reik Löser, Ralf Bergmann, Maxim Frizler, Birgit Mosch, Lilli Dombrowski, Manuela Kuchar, Jörg Steinbach, Michael Gütschow, Jens Pietzsch, Synthesis and Radiopharmacological Characterisation of a Fluorine-18-Labelled Azadipeptide Nitrile as a Potential PET Tracer for in vivo Imaging of Cysteine Cathepsins, ChemMedChem, 2013, 8, 8
  10. 10
    Jerald E. Dumas, Manu O. Platt, Systematic Optimization of Multiplex Zymography Protocol to Detect Active Cathepsins K, L, S, and V in Healthy and Diseased Tissue: Compromise Among Limits of Detection, Reduced Time, and Resources, Molecular Biotechnology, 2013, 54, 3, 1038

    CrossRef

  11. 11
    Francesco Pantano, Alice Zoccoli, Michele Iuliani, Marco Fioramonti, Gaetano Lanzetta, Giuseppe Tonini, Daniele Santini, Targeting Bone Metastases: New Drugs for New Targets, Clinical Reviews in Bone and Mineral Metabolism, 2013, 11, 3-4, 103

    CrossRef

  12. 12
    Dieter Brömme, Handbook of Proteolytic Enzymes, 2013,

    CrossRef

  13. 13
    Manu Platt, Jerald Dumas, Tumor Angiogenesis Regulators, 2013,

    CrossRef

  14. 14
    J.M. Schmit, H.C. Pondenis, A.M. Barger, L.B. Borst, L.D. Garrett, J.M. Wypij, Z.L. Neumann, T.M. Fan, Cathepsin K Expression and Activity in Canine Osteosarcoma, Journal of Veterinary Internal Medicine, 2012, 26, 1
  15. 15
    Katrin Hochdörffer, Khalid Abu Ajaj, Cynthia Schäfer-Obodozie, Felix Kratz, Development of Novel Bisphosphonate Prodrugs of Doxorubicin for Targeting Bone Metastases That Are Cleaved pH Dependently or by Cathepsin B: Synthesis, Cleavage Properties, and Binding Properties to Hydroxyapatite As Well As Bone Matrix, Journal of Medicinal Chemistry, 2012, 55, 17, 7502

    CrossRef

  16. 16
    Tilman D. Rachner, Peyman Hadji, Lorenz C. Hofbauer, Novel therapies in benign and malignant bone diseases, Pharmacology & Therapeutics, 2012, 134, 3, 338

    CrossRef

  17. 17
    Le T Duong, Therapeutic inhibition of cathepsin K—reducing bone resorption while maintaining bone formation, BoneKEy Reports, 2012, 1, 5

    CrossRef

  18. 18
    Justin Sturge, Matthew P. Caley, Jonathan Waxman, Bone metastasis in prostate cancer: emerging therapeutic strategies, Nature Reviews Clinical Oncology, 2011,

    CrossRef

  19. 19
    Aline G. Costa, Natalie E. Cusano, Barbara C. Silva, Serge Cremers, John P. Bilezikian, Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis, Nature Reviews Rheumatology, 2011, 7, 8, 447

    CrossRef

  20. 20
    Anjali Mishra, Yusuke Shiozawa, Kenneth J. Pienta, Russell S. Taichman, Homing of Cancer Cells to the Bone, Cancer Microenvironment, 2011, 4, 3, 221

    CrossRef

  21. 21
    Xiao-lin Shi, Kang Liu, Lian-guo Wu, Interventional value of total flavonoids from Rhizoma Drynariae on Cathepsin K, a potential target of osteoporosis, Chinese Journal of Integrative Medicine, 2011, 17, 7, 556

    CrossRef

  22. 22
    Catera L. Wilder, Keon-Young Park, Philip M. Keegan, Manu O. Platt, Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues, Archives of Biochemistry and Biophysics, 2011, 516, 1, 52

    CrossRef

  23. 23
    Binbin Chen, Manu O Platt, Multiplex Zymography Captures Stage-specific Activity Profiles of Cathepsins K, L, and S in Human Breast, Lung, and Cervical Cancer, Journal of Translational Medicine, 2011, 9, 1, 109

    CrossRef

  24. 24
    Anita Boyapati, Bing Ren, Dong-Er Zhang, SERPINB13 is a novel RUNX1 target gene, Biochemical and Biophysical Research Communications, 2011, 411, 1, 115

    CrossRef

  25. 25
    X Yan, M Takahara, L Xie, Y Oda, T Nakahara, H Uchi, S Takeuchi, Y Tu, Y Moroi, M Furue, Stromal expression of cathepsin K in squamous cell carcinoma, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 3
  26. 26
    Ishita Deb Majumdar, Arvind Devanabanda, Benjamin Fox, Jacob Schwartzman, Huan Cong, John A. Porco, Horst C. Weber, Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro, Biochemical and Biophysical Research Communications, 2011, 416, 3-4, 397

    CrossRef

  27. 27
    R Daniel Bonfil, Michael L Cher, The role of proteolytic enzymes in metastatic bone disease, IBMS BoneKEy, 2011, 8, 1, 16

    CrossRef

  28. 28
    Weiwei A. Li, Zachary T. Barry, Joshua D. Cohen, Catera L. Wilder, Rebecca J. Deeds, Philip M. Keegan, Manu O. Platt, Detection of femtomole quantities of mature cathepsin K with zymography, Analytical Biochemistry, 2010, 401, 1, 91

    CrossRef

  29. 29
    Justyna Szumilo, Franciszek Burdan, Krzysztof Zinkiewicz, Jaroslaw Dudka, Robert Klepacz, Andrzej Dabrowski, Elzbieta Korobowicz, Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma., Folia Histochemica et Cytobiologica, 2010, 47, 4

    CrossRef

  30. 30
    D. Santini, S. Galluzzo, A. Zoccoli, F. Pantano, M.E. Fratto, B. Vincenzi, L. Lombardi, C. Gucciardino, N. Silvestris, E. Riva, S. Rizzo, A. Russo, E. Maiello, G. Colucci, G. Tonini, New molecular targets in bone metastases, Cancer Treatment Reviews, 2010, 36, S6

    CrossRef

  31. 31
    Li Zhang, Xue Hou, Shun Lu, Huilan Rao, Jinghui Hou, Rongzhen Luo, He Huang, Hongyun Zhao, Hong Jian, Zhiwei Chen, Meilin Liao, Xin Wang, Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: A large cohort retrospective study, Lung Cancer, 2010, 67, 1, 114

    CrossRef

  32. 32
    Philippe Clézardin, Bone Cancer, 2010,

    CrossRef

  33. 33
    Pierrick G.J. Fournier, Lauren K. Dunn, Gregory A. Clines, Theresa A. Guise, Bone Cancer, 2010,

    CrossRef

  34. 34
    Izabela Podgorski, Bruce E. Linebaugh, Jennifer E. Koblinski, Deborah L. Rudy, Mackenzie K. Herroon, Mary B. Olive, Bonnie F. Sloane, Bone Marrow-Derived Cathepsin K Cleaves SPARC in Bone Metastasis, The American Journal of Pathology, 2009, 175, 3, 1255

    CrossRef

  35. 35
    Izabela Podgorski, Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?, Future Medicinal Chemistry, 2009, 1, 1, 21

    CrossRef

  36. 36
    Wojciech Naumnik, Wiesława Niklińska, Maria Ossolińska, Elzbieta Chyczewska, Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy., Folia Histochemica et Cytobiologica, 2009, 47, 2

    CrossRef

  37. 37
    Colja Cordes, Babett Bartling, Andreas Simm, Dany Afar, Christine Lautenschläger, Gesine Hansen, Rolf-Edgar Silber, Stefan Burdach, Hans-Stefan Hofmann, Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival, Lung Cancer, 2009, 64, 1, 79

    CrossRef

  38. 38
    Fabien Lecaille, Dieter Brömme, Gilles Lalmanach, Biochemical properties and regulation of cathepsin K activity, Biochimie, 2008, 90, 2, 208

    CrossRef

  39. 39
    Sevgi B Rodan, Le T Duong, Cathepsin K – A new molecular target for osteoporosis, IBMS BoneKEy, 2008, 5, 1, 16

    CrossRef

  40. 40
    Céline Le Gall, Edith Bonnelye, Philippe Clézardin, Cathepsin K inhibitors as treatment of bone metastasis, Current Opinion in Supportive and Palliative Care, 2008, 2, 3, 218

    CrossRef

  41. You have free access to this content41
    Knut Husmann, Roman Muff, Marc E. Bolander, Gobinda Sarkar, Walter Born, Bruno Fuchs, Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis, Molecular Carcinogenesis, 2008, 47, 1
  42. 42
    Francesca M. Tumminello, Carla Flandina, Marilena Crescimanno, Gaetano Leto, Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications, Biomedicine & Pharmacotherapy, 2008, 62, 2, 130

    CrossRef

  43. 43
    Maija P. Valta, Johanna Tuomela, Anders Bjartell, Eeva Valve, H. Kalervo Väänänen, Pirkko Härkönen, FGF-8 is involved in bone metastasis of prostate cancer, International Journal of Cancer, 2008, 123, 1
  44. 44
    Xuenong Zou, Lijin Zou, Ying He, Cody Bünger, Molecular treatment strategies and surgical reconstruction for metastatic bone diseases, Cancer Treatment Reviews, 2008, 34, 6, 527

    CrossRef

  45. 45
    Roger N. Pearse, New Strategies for the Treatment of Metastatic Bone Disease, Clinical Breast Cancer, 2007, 8, S35

    CrossRef

  46. 46
    Julia K.L. Woodward, Ingunn Holen, Robert E. Coleman, David J. Buttle, The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer, Bone, 2007, 41, 6, 912

    CrossRef

  47. 47
    Bruce E. LeRoy, Nanda K. Thudi, Murali V.P. Nadella, Ramiro E. Toribio, Sarah H. Tannehill-Gregg, Adrie van Bokhoven, Deborah Davis, Stephanie Corn, Thomas J. Rosol, New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft, The Prostate, 2006, 66, 11
  48. 48
    Manit Arya, Simon R. Bott, Iqbal S. Shergill, Hashim U. Ahmed, Magali Williamson, Hiten R. Patel, The metastatic cascade in prostate cancer, Surgical Oncology, 2006, 15, 3, 117

    CrossRef

  49. 49
    Izabela Podgorski, Bruce E. Linebaugh, Mansoureh Sameni, Christopher Jedeszko, Sunita Bhagat, Michael L. Cher, Bonnie F. Sloane, Bone Microenvironment Modulates Expression and Activity of Cathepsin B in Prostate Cancer, Neoplasia, 2005, 7, 3, 207

    CrossRef

  50. 50
    Jiaqiang Cai, Craig Jamieson, Jennifer Moir, Zoran Rankovic, Cathepsin K inhibitors, 2000 – 2004, Expert Opinion on Therapeutic Patents, 2005, 15, 1, 33

    CrossRef

  51. 51
    Hitoshi Inoue, Kazuo Nishimura, Daizo Oka, Yasutomo Nakai, Masahiro Shiba, Takashi Tokizane, Yasuyuki Arai, Masashi Nakayama, Kiyonori Shimizu, Natsuki Takaha, Norio Nonomura, Akihiko Okuyama, Prostate cancer mediates osteoclastogenesis through two different pathways, Cancer Letters, 2005, 223, 1, 121

    CrossRef

  52. 52
    Christopher Jedeszko, Bonnie F. Sloane, Cysteine cathepsins in human cancer, Biological Chemistry, 2004, 385, 11

    CrossRef

  53. 53
    Magnus Edlund, Shian-Ying Sung, Leland W.K. Chung, Modulation of prostate cancer growth in bone microenvironments, Journal of Cellular Biochemistry, 2004, 91, 4
  54. 54
    David N. Deaton, Sanjay Kumar, 2004,

    CrossRef